These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Garg M, Kanojia D, Khosla A, Dudha N, Sati S, Chaurasiya D, Jagadish N, Seth A, Kumar R, Gupta S, Gupta A, Lohiya NK, Suri A. Cancer Res; 2008 Oct 15; 68(20):8240-8. PubMed ID: 18922895 [Abstract] [Full Text] [Related]
23. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis. Li Y, Chen D, Su Z, Li Y, Liu J, Jin L, Shi M, Jiang Z, Qi Z, Gui Y, Yang S, Mao X, Wu X, Lai Y. Mol Med Rep; 2016 Feb 15; 13(2):1420-6. PubMed ID: 26648244 [Abstract] [Full Text] [Related]
24. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H. J Urol; 2013 Sep 15; 190(3):1059-68. PubMed ID: 23454155 [Abstract] [Full Text] [Related]
25. miR-206 inhibits renal cell cancer growth by targeting GAK. Wei C, Wang S, Ye ZQ, Chen ZQ. J Huazhong Univ Sci Technolog Med Sci; 2016 Dec 15; 36(6):852-858. PubMed ID: 27924503 [Abstract] [Full Text] [Related]
26. Expression of microRNA-210 in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion. Liu TY, Zhang H, Du SM, Li J, Wen XH. Genet Mol Res; 2016 Mar 04; 15(1):15017746. PubMed ID: 26985942 [Abstract] [Full Text] [Related]
29. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC. Quan J, Pan X, Li Y, Hu Y, Tao L, Li Z, Zhao L, Wang J, Li H, Lai Y, Zhou L, Lin C, Gui Y, Ye J, Zhang F, Lai Y. Biomed Pharmacother; 2019 Feb 04; 110():656-666. PubMed ID: 30551118 [Abstract] [Full Text] [Related]
30. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B. Wang C, Wu C, Yang Q, Ding M, Zhong J, Zhang CY, Ge J, Wang J, Zhang C. Oncotarget; 2016 Nov 08; 7(45):73888-73902. PubMed ID: 27729617 [Abstract] [Full Text] [Related]
35. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells. Liu Y, Zhang M, Qian J, Bao M, Meng X, Zhang S, Zhang L, Zhao R, Li S, Cao Q, Li P, Ju X, Lu Q, Li J, Shao P, Qin C, Yin C. DNA Cell Biol; 2015 Jun 08; 34(6):429-36. PubMed ID: 25811077 [Abstract] [Full Text] [Related]
36. RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of FBXW7. Zhang RL, Aimudula A, Dai JH, Bao YX. Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32588875 [Abstract] [Full Text] [Related]
37. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154. Zhang R, Zhang W, Xu B, Lv C, Hou J, Zhang G. Artif Cells Nanomed Biotechnol; 2020 Dec 31; 48(1):695-702. PubMed ID: 32138544 [Abstract] [Full Text] [Related]